Reducing blood loss dialysis patients
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Division of Nephrology University of California Irvine, California, U.S.A . In using 2 ml or 5 ml syringes, the excess blood then being discarded along with the disposable syringes. By using the smalled and also less expensive insulin synringe, as well as educating our nurses and technicians, we were able to further reduce blood loss.
As most blood tests require serum or plasma, one could further reduce blood wastage by centrifuging the samples and returning the cells to the patient. This requires strict asepsis is both time consuming and inconvenient, but may be useful when large amounts of plasma are required, such as with some research projects.
In conclusion the use of microanalytic laboratory methods leads to as much as 90% reduction in blood loss from laboratory tests without compromising the accuracy of the results. All dialysis facilities are therefore urged to use these methods, which have reliably served pediatric populations for many years. In this issue we are presenting a provocative paper on one mechanism of severe lung injury due to extremes in ventilation-perfusion inequality. Such a mechanism, if confirmed, may increase our understanding of the proper use of mechanical ventilation (MV) in patients with acute pulmonary insufficiency.
In the American study on extracorporeal membrane oxygenation (ECMO), we little recognized the possible deleterious effects of profound ventilation-perfusion inequality. We now believe this lack of understanding may have been a significant factor in the failure of that program to ascribe any beneficial effects to the use of membrane lungs (ML).
We feel that severe ARDS does not represent a unique bacterial, or viral process. Severe ARDS is solely defined by highly abnormal arterial blood gas values in the face of «optimal» pulmonary care as practiced today. As such we prefer to think that a priori, in a large number of cases, if not the vast majority of cases, the disease can be treated, and cured.
In severe ARDS, the ventilation is set customarily so as to provide for adequate alveolar ventilation, and a Pa02 above 60-70 mm Hg. Yet it is another thing entirely to equate this «optimal» care with optimal conditions for the healing of the diseased lungs. While the immediate result may be salutory, this can results in severe ventilation perfusion inequality and may lead to a self perpetuating cycle as described in the extreme in the accompanying article.
First and foremost we must decide whether any embarked course of pulmonary treatment is conducive to the healing of the lungs, and to the ultimate survival of the patient, or whether such treatment will only be a mirage in temporarily improving arterial blood gases, but death the ultimate outcome. Gattinoni et al. have recently used veno-venous bypass with LFPPV-ECC0 2R (low frequency positive pressure ventilation with extracorporeal carbon dioxide removal) in patients meeting ECMO entry criteria, thereby not encroaching on the pulmonary blood
